Alpha Tau Medical Ltd.
DRTS
$10.88
-$0.29-2.60%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | 9.63M | 9.18M | 9.02M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 37.52M | 36.93M | 36.04M | |
| Operating Income | -- | -37.52M | -36.93M | -36.04M | |
| Income Before Tax | -- | -35.04M | -32.36M | -31.74M | |
| Income Tax Expenses | -- | 166.00K | 104.00K | 6.00K | |
| Earnings from Continuing Operations | -- | -35.21 | -32.46 | -31.75 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -35.21M | -32.46M | -31.75M | |
| EBIT | -- | -37.52M | -36.93M | -36.04M | |
| EBITDA | -- | -36.43M | -35.83M | -34.95M | |
| EPS Basic | -- | -0.48 | -0.46 | -0.45 | |
| Normalized Basic EPS | -- | -0.16 | -0.15 | -0.15 | |
| EPS Diluted | -- | -0.48 | -0.46 | -0.45 | |
| Normalized Diluted EPS | -- | -0.16 | -0.15 | -0.15 | |
| Average Basic Shares Outstanding | -- | 291.04M | 280.45M | 279.71M | |
| Average Diluted Shares Outstanding | -- | 291.04M | 280.45M | 279.71M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |